LENSAR Inc (LNSR)
Healthcare
Medical Devices
5.00 $
-3.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns LENSAR Inc (LNSR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 70.6% of the shares are freely tradable; institutional investors hold 52.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
52.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
21.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
70.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
10.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
12Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Brandes Investment Partners & Co | 8.47 | 1,025,176 | +19.7 | 03/31/2026 |
| BlackRock Inc | 5.19 | 628,748 | -1.5 | 03/31/2026 |
| Vanguard Group Inc | 4.26 | 515,725 | +1.6 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.22 | 390,090 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.90 | 229,740 | +5.5 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 1.86 | 224,934 | +0.0 | 03/31/2026 |
| Css LLC | 1.35 | 163,450 | -9.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Brandes Small Cap Value R6 | 4.00 | 484,761 | +14.5 | 03/31/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.28 | 275,971 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.85 | 223,429 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.